SLC39A1 and hepatocellular carcinoma: SLC39A1 was differentially expressed between relapsed and non‐replaced HCC patients by RNA sequencing using our in‐house HCC cohort (Table S1), and high SLC39A1 is associated with poor survival by analyzing the TCGA dataset.